{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Charlotte&page=10&state=North+Carolina", "query": { "state": "North Carolina", "city": "Charlotte", "page": 10 }, "page_size": 10 }, "pagination": { "page": 10, "page_size": 10, "total_count": 953, "total_pages": 96, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Charlotte&page=11&state=North+Carolina&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Charlotte&page=9&state=North+Carolina&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-20T07:20:34.015Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00655876", "title": "Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Esophageal Cancer" ], "interventions": [ { "name": "cetuximab", "type": "DRUG" }, { "name": "cisplatin", "type": "DRUG" }, { "name": "paclitaxel", "type": "DRUG" }, { "name": "radiation therapy", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "RADIATION" ], "sponsor": "Radiation Therapy Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "74 Years", "sex": "ALL", "summary": "18 Years to 74 Years" }, "enrollment_count": 344, "start_date": "2008-06", "completion_date": "2022-05-20", "has_results": true, "last_update_posted_date": "2022-06-14", "last_synced_at": "2026-10-20T07:20:34.015Z", "location_count": 173, "location_summary": "Tucson, Arizona • Auburn, California • Cameron Park, California + 140 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Auburn", "state": "California" }, { "city": "Cameron Park", "state": "California" }, { "city": "Carmichael", "state": "California" }, { "city": "Chico", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00655876" }, { "nct_id": "NCT00667810", "title": "Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Alzheimer Disease" ], "interventions": [ { "name": "bapineuzumab", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "89 Years", "sex": "ALL", "summary": "50 Years to 89 Years" }, "enrollment_count": 901, "start_date": "2008-06", "completion_date": "2013-08", "has_results": true, "last_update_posted_date": "2016-01-08", "last_synced_at": "2026-10-20T07:20:34.015Z", "location_count": 164, "location_summary": "Birmingham, Alabama • Goodyear, Arizona • Phoenix, Arizona + 98 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Goodyear", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00667810" }, { "nct_id": "NCT03728985", "title": "Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Thoracoabdominal Aortic Aneurysm" ], "interventions": [ { "name": "GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "W.L.Gore & Associates", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "ALL", "summary": "19 Years and older" }, "enrollment_count": 102, "start_date": "2019-06-17", "completion_date": "2030-01", "has_results": true, "last_update_posted_date": "2026-09-02", "last_synced_at": "2026-10-20T07:20:34.015Z", "location_count": 42, "location_summary": "Birmingham, Alabama • Scottsdale, Arizona • Los Angeles, California + 34 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03728985" }, { "nct_id": "NCT03105102", "title": "A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Crohn's Disease" ], "interventions": [ { "name": "Placebo for Risankizumab SC", "type": "DRUG" }, { "name": "Risankizumab IV", "type": "DRUG" }, { "name": "Placebo for Risankizumab IV", "type": "DRUG" }, { "name": "Risankizumab SC", "type": "DRUG" }, { "name": "Risankizumab On-Body Injector (OBI)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "16 Years to 80 Years" }, "enrollment_count": 1336, "start_date": "2018-04-09", "completion_date": "2029-02", "has_results": false, "last_update_posted_date": "2026-08-14", "last_synced_at": "2026-10-20T07:20:34.015Z", "location_count": 111, "location_summary": "Mesa, Arizona • Phoenix, Arizona • Tucson, Arizona + 91 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Coronado", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03105102" }, { "nct_id": "NCT01997229", "title": "Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Refractory Generalized Myasthenia Gravis" ], "interventions": [ { "name": "Eculizumab", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Alexion Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 125, "start_date": "2013-12", "completion_date": "2016-06", "has_results": true, "last_update_posted_date": "2019-07-16", "last_synced_at": "2026-10-20T07:20:34.015Z", "location_count": 41, "location_summary": "Birmingham, Alabama • Fresno, California • Los Angeles, California + 35 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Fresno", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01997229" }, { "nct_id": "NCT00000919", "title": "A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "Indinavir sulfate", "type": "DRUG" }, { "name": "Lamivudine/Zidovudine", "type": "DRUG" }, { "name": "Ritonavir", "type": "DRUG" }, { "name": "Hydroxyurea", "type": "DRUG" }, { "name": "Abacavir sulfate", "type": "DRUG" }, { "name": "Amprenavir", "type": "DRUG" }, { "name": "Nelfinavir mesylate", "type": "DRUG" }, { "name": "Efavirenz", "type": "DRUG" }, { "name": "Lamivudine", "type": "DRUG" }, { "name": "Stavudine", "type": "DRUG" }, { "name": "Zidovudine", "type": "DRUG" }, { "name": "Didanosine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": null, "sex": "ALL", "summary": "13 Years and older" }, "enrollment_count": 900, "start_date": null, "completion_date": "2002-11", "has_results": false, "last_update_posted_date": "2012-06-07", "last_synced_at": "2026-10-20T07:20:34.015Z", "location_count": 63, "location_summary": "Birmingham, Alabama • Los Angeles, California • Menlo Park, California + 37 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Menlo Park", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00000919" }, { "nct_id": "NCT03851445", "title": "Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Previously Treated Non-Small Cell Lung Cancer" ], "interventions": [ { "name": "Screening Platform", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "SWOG Cancer Research Network", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10000, "start_date": "2019-02-06", "completion_date": "2029-01-28", "has_results": false, "last_update_posted_date": "2026-05-18", "last_synced_at": "2026-10-20T07:20:34.015Z", "location_count": 1229, "location_summary": "Birmingham, Alabama • Daphne, Alabama • Fairhope, Alabama + 807 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Daphne", "state": "Alabama" }, { "city": "Fairhope", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT03851445" }, { "nct_id": "NCT00265850", "title": "Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Colorectal Cancer" ], "interventions": [ { "name": "bevacizumab", "type": "BIOLOGICAL" }, { "name": "cetuximab", "type": "BIOLOGICAL" }, { "name": "FOLFOX or", "type": "DRUG" }, { "name": "FOLFIRI", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Alliance for Clinical Trials in Oncology", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2334, "start_date": "2005-11", "completion_date": "2018-01", "has_results": true, "last_update_posted_date": "2026-08-07", "last_synced_at": "2026-10-20T07:20:34.015Z", "location_count": 662, "location_summary": "Mobile, Alabama • Anchorage, Alaska • Fort Smith, Arkansas + 468 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Fort Smith", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00265850" }, { "nct_id": "NCT04825678", "title": "A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Migraine" ], "interventions": [ { "name": "Erenumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 240, "start_date": "2021-06-11", "completion_date": "2023-09-28", "has_results": true, "last_update_posted_date": "2024-09-19", "last_synced_at": "2026-10-20T07:20:34.015Z", "location_count": 42, "location_summary": "Huntsville, Alabama • Phoenix, Arizona • Fullerton, California + 38 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Fullerton", "state": "California" }, { "city": "Pomona", "state": "California" }, { "city": "Basalt", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT04825678" }, { "nct_id": "NCT02117414", "title": "Confirmatory Clinical Trial of the Evera MRI System for Conditionally-safe MRI Access", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Implantable Defibrillator" ], "interventions": [ { "name": "MRI scan sequences of the head and chest regions", "type": "DEVICE" }, { "name": "Waiting Period Visit", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "Medtronic Cardiac Rhythm and Heart Failure", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 275, "start_date": "2014-04", "completion_date": "2015-09", "has_results": true, "last_update_posted_date": "2016-11-28", "last_synced_at": "2026-10-20T07:20:34.015Z", "location_count": 25, "location_summary": "Salinas, California • Stanford, California • Hartford, Connecticut + 22 more", "locations": [ { "city": "Salinas", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Hartford", "state": "Connecticut" }, { "city": "Orlando", "state": "Florida" }, { "city": "Springfield", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02117414" } ] }